Hred someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Acadia Pharmaceuticals (ACAD) hired Gudarz Davar as executive vice president and head of research and development. Previously, he worked at Eli Lilly (LLY), where he was vice president, head of global neurology clinical development.